PCM
TBPH icon

Prelude Capital Management’s Theravance Biopharma TBPH Stock Holding History

Prelude Capital Management’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$406K Buy
+25,000
New +$442K 0.03% 594
2019
Q3 		– Sell
-392
Closed -$6K – 2174
2019
Q2 		$6K Buy
+392
New +$7.94K ﹤0.01% 1507
2015
Q1 		– Sell
-5,400
Closed -$81K – 2180
2014
Q4 		$81K Buy
+5,400
New +$94.1K 0.01% 1081
2014
Q3 		– Sell
-2,394
Closed -$76K – 2143
2014
Q2 		$76K Buy
+2,394
New +$72.1K 0.01% 1216

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.43B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.1B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return